These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 5519838)
21. [Comparative study of the effect of fibrinolysin inhibitors on the degranulation grade of basophilic granulocytes]. Frick G; Frick U Z Gesamte Inn Med; 1968 Jun; 23(11):321-5. PubMed ID: 5304218 [No Abstract] [Full Text] [Related]
22. Trans-4-aminomethylcyclohexanecarboxylic acid as a potent antiplasmin agent. Shimizu M; Naito T; Okano A; Aoyagi T Chem Pharm Bull (Tokyo); 1965 Aug; 13(8):1012-4. PubMed ID: 5867824 [No Abstract] [Full Text] [Related]
23. [Inhibitor of fibrinolysis from pancreas pantrypin]. Lakin KM; Efimov VS; Polonskaia LB Farmakol Toksikol; 1969; 32(6):712-5. PubMed ID: 5381603 [No Abstract] [Full Text] [Related]
28. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures. Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948 [No Abstract] [Full Text] [Related]
29. [Subarachnoid hemorrhage caused by a ruptured aneurysm and secondary cerebral vasospasm]. Gómez López PA; López Ferro MO Rev Clin Esp; 1983 Nov; 171(4):231-5. PubMed ID: 6364268 [No Abstract] [Full Text] [Related]
30. Cyclosporine A for the prevention of neurological deficit following subarachnoid hemorrhage. Ryba M; Grieb P; Bidzinski J; Pastuszko M; Dziewiecki C; Iwanska K Stroke; 1991 Apr; 22(4):531. PubMed ID: 2024283 [No Abstract] [Full Text] [Related]
31. [The development of fibrinolysis inhibitors]. Markwardt F Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):5-14. PubMed ID: 4173881 [No Abstract] [Full Text] [Related]
32. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes]. Frick G; Frick U Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):389-403. PubMed ID: 4168276 [No Abstract] [Full Text] [Related]
33. [Pathogenesis of cerebral vasospasm following subarachnoid hemorrhage]. Sasaki T No To Shinkei; 1993 Sep; 45(9):799-808. PubMed ID: 8217406 [No Abstract] [Full Text] [Related]
34. Attempted prevention or treatment of intracranial arterial spasm: a survey. Wilkins RH Neurosurgery; 1980 Feb; 6(2):198-210. PubMed ID: 6767999 [TBL] [Abstract][Full Text] [Related]
35. [Experimental studies on the diffusion of antifibrinolytic agents in fibrin thrombi. A contribution to intrathecal antifibrinolytic therapy in subarachnoid hemorrhages]. Hindersin P; Senf L; Richter M; Endler S Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):313-8. PubMed ID: 6179834 [TBL] [Abstract][Full Text] [Related]
36. [Effect of fibrinolytics and antifibrinolytics on wound healing. Experimental study]. Wilde J; Ampt HJ Z Exp Chir; 1971; 4(4):241-7. PubMed ID: 5317395 [No Abstract] [Full Text] [Related]
37. [On the effect of a new synthetic inhibitor of the fibrinolytic system]. Fischer M; Pavlu C Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440 [No Abstract] [Full Text] [Related]
38. [Comparative studies on the fibrinolysis inhibitors AMCHA, epsilon-ACA and PAMBA]. Fischer M Wien Z Inn Med; 1966 Apr; 47(4):143-53. PubMed ID: 6005160 [No Abstract] [Full Text] [Related]
39. [On the influence of eta-aminocaproic acid, PAMBA and PAMBA derivatives on the antigen-antibody reaction in vitro]. Stein P; Bannath G Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):221-4. PubMed ID: 4174662 [No Abstract] [Full Text] [Related]